General
Halting AstraZeneca coronavirus vaccine rollout in EU an ‘overreaction’, according to experts
European authorities pausing the rollout of the AstraZeneca vaccine after a small number of people developed blood clots is an “overreaction”, according to one leading Australian scientist.
Key points:
- The European Medicines Agency said there have been 30 cases of clot-related events among 5 million vaccinated people
- A cluster of blood clots does not mean the vaccine caused them, according to experts and all other potential causes must be investigated, included COVID-19 infection itself
- More than 11 million people have been vaccinated with the AstraZeneca drug in the UK without evidence of an increase in blood clots
“You can’t ignore these events, but I think it’s an overreaction,” Peter Collignon, an infectious diseases expert from ANU,…
Continue Reading
-
Business21 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News21 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business20 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News20 hours agoDid AI write your accounting expert’s report? – Proctor